The potential role of vascular endothelial growth factor (VEGF) in cartilage. How the angiogenic factor could be involved in the pathogenesis of osteoarthritis?

Osteoarthritis and Cartilage

Volumn 16, Issue 3, 2008, Pages 279-286

  Murata, M ^a   Yudoh, K ^a   Masuko, K ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cartilage; Chondrocyte; Hypoxia; Osteoarthritis; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; INTERLEUKIN 1; INTERLEUKIN 17; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PLACENTAL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; APOPTOSIS; ARTHRITIS; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL GROWTH; CELL METABOLISM; ENCHONDRAL OSSIFICATION; GENETIC CODE; HUMAN; MECHANICAL STRESS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW;

ADULT; ANOXIA; APOPTOSIS; BONE DEVELOPMENT; CARTILAGE, ARTICULAR; CELL SURVIVAL; CHONDROCYTES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INFANT, NEWBORN; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOARTHRITIS; OSTEOPHYTE; STRESS, MECHANICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 39749196140     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.09.003     Document Type: Review

References (77)

1. Iannotti J., Goldstein S., Kuhn J., Lipiello L., Kaplan F., and Zaleske D. The formation and growth of skeletal tissues. Orthopedic Basic Science (2000), American Academy of Orthopaedic Surgeons 77-109
2. Moses M.A., Wiederschain D., Wu I., Fernandez C.A., Ghazizadeh V., Lane W.S., et al. Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci USA 96 6 (1999) 2645-2650
3. Shukunami C., Oshima Y., and Hiraki Y. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun 333 2 (2005) 299-307
4. Dvorak H.F. Angiogenesis: update 2005. J Thromb Haemost 3 8 (2005) 1835-1842
5. Roy H., Bhardwaj S., and Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 580 12 (2006) 2879-2887
6. Bluteau G., Julien M., Magne D., Mallein-Gerin F., Weiss P., Daculsi G., et al. VEGF and VEGF receptors are differentially expressed in chondrocytes. Bone 40 3 (2007) 568-576
7. Ladomery M.R., Harper S.J., and Bates D.O. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Lett 249 2 (2007) 133-142
8. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 13 1 (1999) 9-22
9. Robinson C.J., and Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114 Pt 5 (2001) 853-865
10. Thomas K.A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271 2 (1996) 603-606
11. Rahimi N. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front Biosci (2006) 11818-11829
12. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 6 (1998) 735-745
13. Shweiki D., Itin A., Neufeld G., Gitay-Goren H., and Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91 5 (1993) 2235-2243
14. Germeyer A., Hamilton A.E., Laughlin L.S., Lasley B.L., Brenner R.M., Giudice L.C., et al. Cellular expression and hormonal regulation of neuropilin-1 and -2 messenger ribonucleic acid in the human and rhesus macaque endometrium. J Clin Endocrinol Metab 90 3 (2005) 1783-1790
15. Street J., Bao M., deGuzman L., Bunting S., Peale Jr. F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99 15 (2002) 9656-9661
16. Provot S., and Schipani E. Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun (2005) 328658-328665
17. Gerber H., Vu T., Ryan A., Kowalski J., Werb Z., and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5 6 (1999) 623-628
18. Carlevaro M., Cermelli S., Cancedda R., and Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci (2000) 11359-11360
19. Maes C., Carmeliet P., Moermans K., Stockmans I., Smets N., Collen D., et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111 1-2 (2002) 61-73
20. Zelzer E., Mamluk R., Ferrara N., Johnson R.S., Schipani E., and Olsen B.R. VEGFA is necessary for chondrocyte survival during bone development. Development 131 9 (2004) 2161-2171
21. Maes C., Stockmans I., Moermans K., Van Looveren R., Smets N., Carmeliet P., et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 113 2 (2004) 188-199
22. Horner A., Bishop N., Bord S., Beeton C., Kalsall A., Coleman N., et al. Immunolocalization of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 194 Pt 4 (1999) 519-524
23. Kusafuka K., Hiraki Y., Shukunami C., Kayano T., and Takemura T. Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage. Acta Histochem 104 2 (2002) 167-175
24. Lin C., McGough R., Aswad B., Block J.A., and Terek R. Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res 22 6 (2004) 1175-1181
25. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 9 (1996) 4604-4613
26. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12 2 (1998) 149-162
27. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 36 1 (2004) 1-12
28. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 13 6 (1970) 769-776
29. Hollander A.P., Corke K.P., Freemont A.J., and Lewis C.E. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 44 7 (2001) 1540-1544
30. Giatromanolaki A., Sivridis E., Maltezos E., Athanassou N., Papazoglou D., Gatter K.C., et al. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 5 4 (2003) R193-R201
31. 2! See what HIF can do!. Ann Rheum Dis 64 7 (2005) 971-980
32. Distler J.H., Wenger R.H., Gassmann M., Kurowska M., Hirth A., Gay S., et al. Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 50 1 (2004) 10-23
33. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., and Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15 21 (2001) 2865-2876
34. Schipani E. Hypoxia and HIF-1 alpha in chondrogenesis. Semin Cell Dev Biol 16 4-5 (2005) 539-546
35. Yudoh K., Nakamura H., Masuko-Hongo K., Kato T., and Nishioka K. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1 alpha in articular chondrocytes: involvement of HIF-1 alpha in the pathogenesis of osteoarthritis. Arthritis Res Ther 7 4 (2005) R904-R914
36. Pfander D., Cramer T., Schipani E., and Johnson R.S. HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116 Pt 9 (2003) 1819-1826
37. Tanaka S., Hamanishi C., Kikuchi H., and Fukuda K. Factors related to degradation of articular cartilage in osteoarthritis: a review. Semin Arthritis Rheum 27 6 (1998) 392-399
38. Torzilli P.A., and Grigiene R. Continuous cyclic load reduces proteoglycan release from articular cartilage. Osteoarthritis Cartilage 6 4 (1998) 260-268
39. Fujisawa T., Hattori T., Takahashi K., Kuboki T., Yamashita A., and Takigawa M. Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. J Biochem (Tokyo) 125 5 (1999) 966-975
40. Akagi M., Nishimura S., Yoshida K., Kakinuma T., Sawamura T., Munakata H., et al. Cyclic tensile stretch load and oxidized low density lipoprotein synergistically induce lectin-like oxidized ldl receptor-1 in cultured bovine chondrocytes, resulting in decreased cell viability and proteoglycan synthesis. J Orthop Res 24 8 (2006) 1782-1790
41. Loeser R.F. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 54 5 (2006) 1357-1360
42. Pufe T., Lemke A., Kurz B., Petersen W., Tillmann B., Grodzinsky A.J., et al. Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 164 1 (2004) 185-192
43. Pufe T., Kurz B., Petersen W., Varoga D., Mentlein R., Kulow S., et al. The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system. Ann Anat 187 5-6 (2005) 461-472
44. Wong M., Siegrist M., and Goodwin K. Cyclic tensile strain and cyclic hydrostatic pressure differentially regulate expression of hypertrophic markers in primary chondrocytes. Bone 33 4 (2003) 685-693
45. Turpaev K., Litvinov D., Dubovaya V., Panasyuk A., Ivanov D., and Prassolov V. Induction of vascular endothelial growth factor by nitric oxide in cultured human articular chondrocytes. Biochimie 83 6 (2001) 515-522
46. Honorati M.C., Cattini L., and Facchini A. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage 12 9 (2004) 683-691
47. Murata M., Yudoh K., Nakamura H., Kato T., Inoue K., Chiba J., et al. Distinct signaling pathways are involved in hypoxia- and IL-1-induced VEGF expression in human articular chondrocytes. J Orthop Res 24 7 (2006) 1544-1554
48. Kanata S., Akagi M., Nishimura S., Hayakawa S., Yoshida K., Sawamura T., et al. Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma. Biochem Biophys Res Commun 348 3 (2006) 1003-1010
49. Fay J., Varoga D., Wruck C.J., Kurz B., Goldring M.B., and Pufe T. Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants. Arthritis Res Ther 8 6 (2006) R189
50. Tomiyama T., Fukuda K., Yamazaki K., Hashimoto K., Ueda H., Mori S., et al. Cyclic compression loaded on cartilage explants enhances the production of reactive oxygen species. J Rheumatol 34 3 (2007) 556-562
51. Green D.M., Noble P.C., Ahuero J.S., and Birdsall H.H. Cellular events leading to chondrocyte death after cartilage impact injury. Arthritis Rheum 54 5 (2006) 1509-1517
52. Duyndam M.C., Hulscher S.T., van der Wall E., Pinedo H.M., and Boven E. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. J Biol Chem 278 9 (2003) 6885-6895
53. Kao Y.H., Yu C.L., Chang L.W., and Yu H.S. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem Res Toxicol 16 4 (2003) 460-468
54. Sandal L., Heinegard D., and Hering T. Cell biology, biochemistry, and molecular biology of articular cartilage in osteoarthritis. Osteoarthritis: Diagnosis and Medical/Surgical Management (2007), Lippincott Williams & Wilkins 73-106
55. Pufe T., Petersen W., Tillmann B., and Mentlein R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44 5 (2001) 1082-1088
56. Pfander D., Kortje D., Zimmermann R., Weseloh G., Kirsch T., Gesslein M., et al. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 60 11 (2001) 1070-1073
57. Enomoto H., Inoki I., Komiya K., Shiomi T., Ikeda E., Obata K., et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 162 1 (2003) 171-181
58. Shakibaei M., Schulze-Tanzil G., Mobasheri A., Beichler T., Dressler J., and Schwab W. Expression of the VEGF receptor-3 in osteoarthritic chondrocytes: stimulation by interleukin-1 beta and association with beta 1-integrins. Histochem Cell Biol 120 3 (2003) 235-241
59. Haywood L., McWilliams D.F., Pearson C.I., Gill S.E., Ganesan A., Wilson D., et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 48 8 (2003) 2173-2177
60. Mankin H., Mow V., and Buckwalter J. Articular cartilage repair and osteoarthritis. Orthopaedic Basic Science (2000), American Academy of Orthopaedic Surgeons 471-488
61. Hashimoto S., Creighton-Achermann L., Takahashi K., Amiel D., Coutts R.D., and Lotz M. Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 10 3 (2002) 180-187
62. Mentlein R., and Pufe T. New functions of angiogenic peptides in osteoarthritic cartilage. Curr Rheumatol Rev (2005) 137-143
63. Pufe T., Harde V., Petersen W., Goldring M.B., Tillmann B., and Mentlein R. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 202 3 (2004) 367-374
64. Komiya K., Enomoto H., Inoki I., Okazaki S., Fujita Y., Ikeda E., et al. Expression of ADAM15 in rheumatoid synovium: upregulation by vascular endothelial growth factor and possible implications for angiogenesis. Arthritis Res Ther 7 6 (2005) R1158-R1173
65. Sharif M., Whitehouse A., Sharman P., Perry M., and Adams M. Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. Arthritis Rheum 50 2 (2004) 507-515
66. Aigner T., Haag J., Martin J., and Buckwalter J. Osteoarthritis: aging of matrix and cells-going for a remedy. Curr Drug Targets 8 2 (2007) 325-331
67. Liu W., Ahmad S.A., Reinmuth N., Shaheen R.M., Jung Y.D., Fan F., et al. Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis 5 4 (2000) 323-328
68. Kim W.U., Kang S.S., Yoo S.A., Hong K.H., Bae D.G., Lee M.S., et al. Interaction of vascular endothelial growth factor 165 with neuropilin-1 protects rheumatoid synoviocytes from apoptotic death by regulating Bcl-2 expression and Bax translocation. J Immunol 177 8 (2006) 5727-5735
69. Kim H.A., Lee Y.J., Seong S.C., Choe K.W., and Song Y.W. Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 27 2 (2000) 455-462
70. Lee M.S., Trindade M.C., Ikenoue T., Goodman S.B., Schurman D.J., and Smith R.L. Regulation of nitric oxide and bcl-2 expression by shear stress in human osteoarthritic chondrocytes in vitro. J Cell Biochem 90 1 (2003) 80-86
71. Iannone F., De Bari C., Scioscia C., Patella V., and Lapadula G. Increased Bcl-2/p53 ratio in human osteoarthritic cartilage: a possible role in regulation of chondrocyte metabolism. Ann Rheum Dis 64 2 (2005) 217-221
72. Surendran S., Kim S.H., Jee B.K., Ahn S.H., Gopinathan P., and Han C.W. Anti-apoptotic Bcl-2 gene transfection of human articular chondrocytes protects against nitric oxide-induced apoptosis. J Bone Joint Surg Br 88 12 (2006) 1660-1665
73. Yagi R., McBurney D., Laverty D., Weiner S., and Horton Jr. W.E. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 23 5 (2005) 1128-1138
74. Yagi R., McBurney D., and Horton Jr. W.E. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway. J Biol Chem 280 34 (2005) 30517-30525
75. Dai S.M., Shan Z.Z., Nakamura H., Masuko-Hongo K., Kato T., Nishioka K., et al. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced downregulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum 54 3 (2006) 818-831
76. Pelletier J.P., Martel-Pelletier J., and Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44 6 (2001) 1237-1247
77. Masuko-Hongo K., and Yudoh K. The role of inflammatory mediators in cartilage. Curr Rheumatol Rev 1 2 (2005) 119-124